Simon Wandel

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

Stephan Windecker, Patrick W. Serruys, Simon Wandel et al. · The Lancet · 2008 · 650 citations

Percutaneous Coronary Intervention, Endovascular Technique, Cardiovascular Disease +10

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study

Paolo A. Ascierto, Dirk Schadendorf, Carola Berking et al. · The Lancet Oncology · 2013 · 638 citations

Tumor Biology, Open-label Phase 2, Medicine +12

Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis

Bruno R. da Costa, Stephan Reichenbach, Noah Keller et al. · The Lancet · 2017 · 498 citations

Network Meta-analysis, Anti-inflammatory, Health Sciences +12

RETRACTED: Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis

Bruno R. da Costa, Stephan Reichenbach, Noah Keller et al. · The Lancet · 2016 · 422 citations

Network Meta-analysis, Hip Osteoarthritis, Pain Medicine +10

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study

Peter Barlis, E. Regar, Patrick W. Serruys et al. · European Heart Journal · 2009 · 247 citations · Full text